Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma.

BACKGROUND AND AIMS EUS has become an interventional technique in which a needle may be used as a vehicle to deliver therapeutic agents. Laser ablation (LA) has been used to treat many primary and secondary neoplasms. This study aimed to assess the feasibility of EUS-guided LA for unresectable (UR) pancreatic cancer. METHODS Patients with stage IIb-III pancreatic cancer underwent EUS-guided LA. All patients were unresponsive to previous chemoradiotherapy. LA was performed by using a 300-μm flexible fiber preloaded onto a 22-gauge fine needle. A 1064-nm wavelength neodymium-yttrium aluminum garnet (Nd:YAG) laser light with different power settings of 2 W for 800 J, 1000 J, and 1200 J; 3 W for 800 J, 1000 J, and 1200 J; and 4 W for 800 J, 1000 J, and 1200 J was used. Each patient was treated with a single application of 1 of these settings. The application time of the power settings ranged from 200 to 600 seconds. RESULTS Nine patients (median age, 74.7; range 55-85) underwent Nd:Yag LA. The mean size of the focal lesion was 35.4 mm (range, 21-45). The ablation area, demonstrated by 24-hour CT, ranged from .4 cm3 (for the lower power setting of 2 W/800 J) to a maximum of 6.4 cm3 (for 4 W/1000 J). The procedure was completed in all 9 patients without adverse events. CONCLUSION In our human experience, EUS-guided LA was feasible and well tolerated in patients with UR pancreatic cancer.

[1]  Sergio Silvestri,et al.  US-guided application of Nd:YAG laser in porcine pancreatic tissue: an ex vivo study and numerical simulation. , 2013, Gastrointestinal endoscopy.

[2]  G. Narayanan,et al.  A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma , 2012, BMC Cancer.

[3]  T. Conroy,et al.  Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Stasi,et al.  Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. , 2012, AJR. American journal of roentgenology.

[5]  G. Barnett,et al.  Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overview , 2016, Expert review of neurotherapeutics.

[6]  Laser nerve‐sparing laparoscopic radical prostatectomy: a feasibility study , 2007, BJU international.

[7]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Radiology.

[8]  C. Bassi,et al.  Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer , 2010, The British journal of surgery.

[9]  R. Regine,et al.  Complications of laser ablation for hepatocellular carcinoma: a multicenter study. , 2008, Radiology.

[10]  Sergio Silvestri,et al.  Theoretical Analysis and Experimental Evaluation of Laser-Induced Interstitial Thermotherapy in Ex Vivo Porcine Pancreas , 2012, IEEE Transactions on Biomedical Engineering.

[11]  Jing Chen,et al.  High operative risk of cool‐tip radiofrequency ablation for unresectable pancreatic head cancer , 2006, Journal of surgical oncology.

[12]  Emiliano Schena,et al.  Real-time temperature monitoring and estimation of thermal damage in pancreas undergoing magnetic resonance-guided laser ablation: First in vivo study , 2017, 2017 IEEE International Instrumentation and Measurement Technology Conference (I2MTC).

[13]  N. Reddy,et al.  Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. , 2015, Gastrointestinal endoscopy.

[14]  M. Pocard,et al.  Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  Myung-Hwan Kim,et al.  Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter , 2015, Endoscopy.

[16]  B. Petersen,et al.  A lexicon for endoscopic adverse events: report of an ASGE workshop. , 2010, Gastrointestinal endoscopy.

[17]  Martin G Mack,et al.  Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data. , 2004, Radiology.

[18]  H. Rammensee,et al.  More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of Cancer , 2011, Clinical & developmental immunology.

[19]  M. Reni,et al.  Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. , 2012, Gastrointestinal endoscopy.

[20]  C. Bassi,et al.  Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma , 2012, The British journal of surgery.

[21]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[22]  Emiliano Schena,et al.  Endoscopic ultrasound-guided Nd:YAG laser ablation of recurrent pancreatic neuroendocrine tumor: a promising revolution? , 2014, Endoscopy.

[23]  E. Papini,et al.  Outcomes and Risk Factors for Complications of Laser Ablation for Thyroid Nodules: A Multicenter Study on 1531 Patients. , 2015, The Journal of clinical endocrinology and metabolism.

[24]  Sergio Silvestri,et al.  EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. , 2010, Gastrointestinal endoscopy.